Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma
Authors:
Open Access
- 11 January 2012
- journal article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 25 (7) , 638-644
Abstract
Summary. In the light of increasing evidence supporting cancer stem cells (CSCs) theory, the expression of two stem cell markers, CD133 and adenosine triphosphaKeywords
This publication has 30 references indexed in Scilit:
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781Journal of Clinical Oncology, 2008
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma PatientsClinical Cancer Research, 2008
- Identification of Cancer Stem Cell–Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell LineCancer Research, 2007
- Identification of Pancreatic Cancer Stem CellsCancer Research, 2007
- Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProceedings of the National Academy of Sciences, 2007
- A human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature, 2006
- Identification of human brain tumour initiating cellsNature, 2004
- Breast Cancer Resistance Protein Impacts Clinical Outcome in Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung CancerClinical Cancer Research, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- TNM classification of malignant tumors, fifth edition (1997)Cancer, 1997